Panel: Is It Really Up to LCA to Certify Centers?
Moments before the hearing was closed to public comments, guest committee member Michael Gould asked Fenton-Ambrose to describe LCA’s certification program for screening centers:
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
